Inmolecule Nanotech, S.A. — Investor Relations & Filings
Inmolecule Nanotech, S.A. is a research and development company specializing in nanotechnology. The company operates a proprietary Nano-Phyto-Chemistry platform that utilizes plant-derived compounds and extracts at a nanometric scale. This technology manipulates chemical components such as flavonoids and terpenes to create active ingredient nanoparticles. The stated benefits of this process include enhanced bioavailability, reduced toxicity, and fewer inflammatory side effects. The company's developments are applied in the biomedical, home, and personal care sectors. Products derived from its platform include surface sanitizers, disinfectants, and dietary supplements.
Recent filings
No filings indexed yet
We are still gathering filings for Inmolecule Nanotech, S.A.. .
No filings match the current filters
Try clearing the filters, or .
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Predict S.p.A.
Develops and distributes AI medical solutions for imaging, …
|
PRE | IT | Professional, scientific and te… |
|
PRESCIENT THERAPEUTICS LIMITED
Clinical-stage oncology firm developing modular cell therap…
|
PTX | AU | Professional, scientific and te… |
|
PreveCeutical Medical
Health sciences company researching and developing innovati…
|
PREV | CA | Professional, scientific and te… |
|
ProMIS Neurosciences Inc.
Develops selective antibody therapeutics for neurodegenerat…
|
PMN | CA | Professional, scientific and te… |
|
Propanc Biopharma, Inc.
Clinical-stage company developing cancer treatments to prev…
|
PPCB | US | Professional, scientific and te… |
|
ProQR Therapeutics N.V.
Develops RNA therapies for severe genetic disorders using i…
|
PRQR | NL | Professional, scientific and te… |
|
Prostatype Genomics AB
Develops a genetic test that assesses prostate cancer aggre…
|
PROGEN | SE | Professional, scientific and te… |
|
Protagenic Therapeutics, Inc.\new
Develops peptide-based therapeutics for stress-related neur…
|
PTIX | US | Professional, scientific and te… |
|
Protara Therapeutics, Inc.
Clinical-stage biopharma developing therapies for cancer an…
|
TARA | US | Professional, scientific and te… |
|
PROTEINA CO.,LTD.
A biotech firm analyzing protein interactions for drug and …
|
468530 | KR | Professional, scientific and te… |
Inmolecule Nanotech, S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14958/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14958 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14958 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14958 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14958}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Inmolecule Nanotech, S.A. (id: 14958)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.